HCPCS S9370: Home Intermittent Anti-Emetic Injection Therapy, Per Diem
HCPCS Level II code S9370 covers per diem administrative and professional pharmacy services, care coordination, and supplies and equipment associated with home-based intermittent anti-emetic injection therapy, with drugs and nursing visits billed separately. This code matters nationally as home infusion and supportive therapies expand for symptom management in oncology, palliative care, and other outpatient settings, affecting reimbursement workflows and care coordination across payers. Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of what S9370 represents, the clinical and operational contexts for home intermittent anti-emetic injections, and what to watch for in payer coverage patterns and billing practice. The publication summarizes common modifiers and implementation considerations, highlights typical sites of service and service components, and identifies gaps where input data is not available. It also outlines implications for claims processing and documentation requirements tied to per diem administrative and pharmacy services. Data not available in the input is noted where applicable.
Customize your policy alerts
Sign up for hcpcs S9370 policy alerts
Get alerted when payer policies referencing S9370 are released or updated.
Monitor payer policy activity
Billing Code Overview
HCPCS Level II code S9370 describes home therapy, intermittent anti-emetic injection therapy; administrative services, professional pharmacy services, care coordination, and all necessary supplies and equipment (drugs and nursing visits coded separately), per diem. The primary service type is home-based supportive infusion/medication administration focused on intermittent anti-emetic injections. The typical site of service is the patients home, delivered through home health or home infusion programs. Data not available in the input.